These findings suggest that dietary selenium supplementation can effectively resist hepatic injury and insulin resistance during NAFLD development, and regulate the KEAP1/NRF2 pathway to resist oxidative stress by promoting SEPP1 synthesis. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.